Home » Topics » BioWorld Science

BioWorld Science
RSS

Potential hypertension treatment from Pola

July 19, 1996

NEP inhibitors described by Tanabe Seiyaku

July 19, 1996

Angiotensin II antagonists described by Kotobuki Seiyaku

July 19, 1996

Anti-IgE monoclonal antibody lawsuits settled

July 19, 1996

Kyoto Pharm. and Asahi Chem. to codevelop AKY-953

July 19, 1996

5-Lipoxygenase inhibitors reported by Pfizer

July 19, 1996

Trial results described for methylphenidate in head injury patients

July 19, 1996

Adenosine A1 antagonists described by German universities

July 19, 1996

Muscarinic cholinergic ligands described by Novo Nordisk

July 19, 1996

Athena Neuroscience's BotB successfully completes phase II in cervical dystonia

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...